Position in VTRS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$603
-$764 QoQ
Shares Held
38
-75.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#947
of 1,016 holders
Holding Since
Dec 2022
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DecisionPoint Financial, LLC holds $8,474 across 13 Drug Manufacturers - Specialty & Generic names. VTRS ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRLV |
Trulieve Cannabis Corp.
|
416 | $4,089 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
2 | $1,083 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
6 | $665 | |
| 4 | LQDA |
Liquidia Corp
|
8 | $637 | |
| 5 | VTRS |
Viatris Inc
This page
|
38 | $603 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
14 | $344 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
2 | $337 | |
| 8 | ZTS |
Zoetis Inc.
|
4 | $287 |
All Filings in VTRS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $603 | 38 | Shares | Sole | 2026-08-05 | |
| 2025-03-31 | $1,367 | 157 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $6,934 | 557 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $6,466 | 557 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $5,920 | 557 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $6,650 | 557 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $1,700 | 157 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $1,548 | 157 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $1,566 | 157 | Shares | Sole | 2023-09-26 | |
| 2023-03-31 | $1,510 | 157 | Shares | Sole | 2023-09-26 | |
| 2022-12-31 | $1,747 | 157 | Shares | Sole | 2023-09-26 | |
| No filing history on record for this holder in this stock. | ||||||